Cargando…
In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori
The most evident challenge to treatment of Helicobacter pylori, a bacterium responsible for gastritis, peptic ulcers and gastric cancer, is the increasing rate of resistance to all currently used therapeutic antibiotics. Thus, the development of novel therapies is urgently required. N-geranyl-N'...
Autores principales: | Makobongo, Morris O., Einck, Leo, Peek, Richard M., Merrell, D. Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723868/ https://www.ncbi.nlm.nih.gov/pubmed/23935905 http://dx.doi.org/10.1371/journal.pone.0068917 |
Ejemplares similares
-
In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites
por: Baek, Kyung-Hwa, et al.
Publicado: (2022) -
Antitubercular Nanocarrier Combination Therapy: Formulation
Strategies and in Vitro Efficacy for Rifampicin and
SQ641
por: D’Addio, Suzanne M., et al.
Publicado: (2015) -
Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
por: Bukhdruker, Sergey, et al.
Publicado: (2020) -
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits
por: Egbelowo, Oluwaseun, et al.
Publicado: (2021) -
Special issue: Helicobacter pylori
por: Peek, Richard M
Publicado: (2013)